Tests developed by the innovative Slovak company Glycanostics bring hope and solutions for the early
non-invasive diagnosis of prostate cancer and 10 other types of cancer. With an accuracy of more than
85% these tests outperform ordinary PSA tests and other competitive solutions. All you need is a drop
of blood. They are rapid, accurate, suitable for mass screening, affordable and painless. With these tests
both the course of the disease and the success of the treatment can be monitored. This project was
supported by several European grants. A Slovak idea – a new health opportunity.